Needham & Company LLC reiterated their buy rating on shares of DocGo (NASDAQ:DCGO – Free Report) in a research report released on Tuesday morning, Marketbeat reports. Needham & Company LLC currently has a $3.00 price objective on the stock.
Several other equities research analysts have also commented on DCGO. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research report on Monday, May 11th. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, DocGo currently has an average rating of “Hold” and an average price target of $2.38.
View Our Latest Stock Report on DCGO
DocGo Stock Up 2.4%
DocGo (NASDAQ:DCGO – Get Free Report) last issued its earnings results on Monday, August 17th. The company reported ($0.16) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The company had revenue of $73.42 million during the quarter, compared to analysts’ expectations of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. Sell-side analysts anticipate that DocGo will post -0.17 earnings per share for the current fiscal year.
Hedge Funds Weigh In On DocGo
Large investors have recently bought and sold shares of the business. Neuberger Berman Group LLC purchased a new position in DocGo during the fourth quarter worth approximately $29,000. Cerity Partners LLC purchased a new stake in shares of DocGo in the second quarter valued at approximately $37,000. Public Employees Retirement System of Ohio acquired a new position in shares of DocGo during the 4th quarter worth approximately $40,000. Engineers Gate Manager LP acquired a new position in shares of DocGo during the 2nd quarter worth approximately $52,000. Finally, Diversify Advisory Services LLC purchased a new position in shares of DocGo during the 2nd quarter valued at approximately $53,000. Institutional investors and hedge funds own 56.44% of the company’s stock.
About DocGo
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Read More
- Five stocks we like better than DocGo
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
